2018 Gastroesophageal Reflux Disease (GERD) Drug Development- Pipeline Analysis Report

  • ID: 4527600
  • Report
  • 53 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Cancer Advances Inc
  • CJ HealthCare
  • Effexus Pharmaceutical
  • Eisai Co Ltd
  • Il-Yang Pharm.Co.,Ltd
  • Ironwood Pharmaceuticals
  • MORE
With an estimated 25 million people being affected by Gastroesophageal reflux disease (GERD) in the US, it is considered as one of the most common GI Disorders. GERD causes stomach contents regurgitate into the esophagus, causing damage to esophagus.

Around 30 companies and universities are focusing on developing treatment options for Gastroesophageal Reflux Disease (GERD).

To assist investigators and funding and regulatory organizations, the publisher has come up with a comprehensive report on Gastroesophageal Reflux Disease (GERD) pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Gastroesophageal Reflux Disease (GERD) pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Gastroesophageal Reflux Disease (GERD) pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cancer Advances Inc
  • CJ HealthCare
  • Effexus Pharmaceutical
  • Eisai Co Ltd
  • Il-Yang Pharm.Co.,Ltd
  • Ironwood Pharmaceuticals
  • MORE
1.1 List of Figures
1.2 List of Tables

2 Gastroesophageal Reflux Disease (GERD) Pipeline Analysis
2.1 Disease and Pipeline Overview
2.2 Gastroesophageal Reflux Disease (GERD) Pipeline Snapshot
2.3 Gastroesophageal Reflux Disease (GERD) Pipeline by Phase
2.4 Gastroesophageal Reflux Disease (GERD) Pipeline by Company
2.5 Gastroesophageal Reflux Disease (GERD) Pipeline by Mechanism of Action

3 Gastroesophageal Reflux Disease (GERD)- Company Wise Pipeline Analysis
  • Cancer Advances Inc
  • CJ HealthCare
  • Daewoong Pharmaceutical Co
  • Effexus Pharmaceutical
  • Eisai Co Ltd
  • Il-Yang Pharm.Co.,Ltd
  • Ironwood Pharmaceuticals
  • Jeil Pharmaceutical Co Ltd
  • Jiangsu Aosaikang Pharmaceutical
  • Mitsubishi Pharma Corporation
  • New Haven Pharmaceuticals
  • Pfizer
  • RaQualia Pharma Inc
  • Renexxion LLC
  • Rottapharm
  • Takeda Pharmaceutical Co
  • Trio Medicines Ltd
  • Yooyoung Pharm Co Ltd
  • Yuyu Pharma Inc
4 Gastroesophageal Reflux Disease (GERD) R&D Pipeline Snapshots
  • Drug wise Pipeline Details
  • Therapeutic Candidate Name
  • Originator
  • Co-Developer/ License Partner
  • Orphan Drug Designation
  • Development Phase
  • Mechanism of Action
  • Current Status
  • Ongoing Clinical Trial Details
5 Recent Developments in Gastroesophageal Reflux Disease (GERD) Pipeline

6 Appendix
6.1 About the Publisher
6.2 Sources and Research Methodology

1.1 List of Figures
Figure 1: Gastroesophageal Reflux Disease (GERD) Pipeline by Phase, H1- 2018
Figure 2: Gastroesophageal Reflux Disease (GERD) Pipeline by Companies, H1- 2018
Figure 3: Company Wise Pipeline Drug Phases, H1- 2018
Figure 4: Gastroesophageal Reflux Disease (GERD) Pipeline by Mechanism of Action, H1- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H1- 2018

1.2 List of Tables
Table 1: Gastroesophageal Reflux Disease (GERD) Pipeline by Phase, H1- 2018
Table 2: Gastroesophageal Reflux Disease (GERD) Pipeline by Companies, H1- 2018
Table 3: Gastroesophageal Reflux Disease (GERD) Pipeline by Mechanism of Action, H1- 2018
Table 4: Cancer Advances Inc Gastroesophageal Reflux Disease Pipeline, May 2018
Table 5: CJ HealthCare Gastroesophageal Reflux Disease Pipeline, May 2018
Table 6: Daewoong Pharmaceutical Co Gastroesophageal Reflux Disease Pipeline, May 2018
Table 7: Effexus Pharmaceutical Gastroesophageal Reflux Disease Pipeline, May 2018
Table 8: Eisai Co Ltd Gastroesophageal Reflux Disease Pipeline, May 2018
Table 9: Eisai Co Ltd Gastroesophageal Reflux Disease Pipeline, May 2018
Table 10: Il-Yang Pharm.Co.,Ltd Gastroesophageal Reflux Disease Pipeline, May 2018
Table 11: Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Pipeline, May 2018
Table 12: Jeil Pharmaceutical Co Ltd Gastroesophageal Reflux Disease Pipeline, May 2018
Table 13: Jiangsu Aosaikang Pharmaceutical Gastroesophageal Reflux Disease Pipeline, May 2018
Table 14: Mitsubishi Pharma Corporation Gastroesophageal Reflux Disease Pipeline, May 2018
Table 15: New Haven Pharmaceuticals Gastroesophageal Reflux Disease Pipeline, May 2018
Table 16: Pfizer Gastroesophageal Reflux Disease Pipeline, May 2018
Table 17: RaQualia Pharma Inc Gastroesophageal Reflux Disease Pipeline, May 2018
Table 18: Renexxion LLC Gastroesophageal Reflux Disease Pipeline, May 2018
Table 19: Rottapharm Gastroesophageal Reflux Disease Pipeline, May 2018
Table 20: Takeda Pharmaceutical Co Gastroesophageal Reflux Disease Pipeline, May 2018
Table 21: Trio Medicines Ltd Gastroesophageal Reflux Disease Pipeline, May 2018
Table 22: Yooyoung Pharm Co Ltd Gastroesophageal Reflux Disease Pipeline, May 2018
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Cancer Advances Inc
  • CJ HealthCare
  • Daewoong Pharmaceutical Co
  • Effexus Pharmaceutical
  • Eisai Co Ltd
  • Il-Yang Pharm.Co.,Ltd
  • Ironwood Pharmaceuticals
  • Jeil Pharmaceutical Co Ltd
  • Jiangsu Aosaikang Pharmaceutical
  • Mitsubishi Pharma Cor
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll